Management Decisions in Crohn’s Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels

BACKGROUND: There is controversy about the proactive clinical application of therapeutic drug monitoring (TDM) of biologic drugs in Crohn’s disease (CD). One way to practically assess this is to examine how TDM influences management decisions. We examined how knowledge of proactive and reactive anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yang, Wen, Amy, Selvanderan, Shane P, Xuan, Wei, Andrews, Jane M, Koo, Jenn H, Williams, Astrid-Jane, Ng, Watson, Connor, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802446/
https://www.ncbi.nlm.nih.gov/pubmed/36776656
http://dx.doi.org/10.1093/crocol/otab042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802446/
https://www.ncbi.nlm.nih.gov/pubmed/36776656
http://dx.doi.org/10.1093/crocol/otab042

Ejemplares similares